Aspen Aerogels faces two main questions in late 2001: who to approach in its fundraising efforts and how much investment it should seek . It would make more sense for Aspen Aerogels to seek additional funding from Rockport Capital. As Rockport Capital already provided $4 million to Aspen Aerogels in May 2001, they would most likely be willing to invest additional funds due to the desire to continue growing the company. If Aspen Aerogels fails to secure additional financing and were to file for bankruptcy, Rockport Capital would lose everything it has already invested in the company. Additionally, Rockport may wish to increase its investment to establish additional control such as obtaining board seats, rights of first refusal, liquidation preference, etc., and to avoid dilute, assuming that its original shareholder rights agreement did not already contain these protective measures. provisions. To consider from another perspective, Rockport Capital may not want to invest additional funds for various reasons. If Rockport Capital views Aspen Aerogels as a likely failure, they won't want to continue investing their money in what could ultimately be a completely unprofitable business. Additionally, Rockport Capital already has relatively significant control over the company. Based on Table 3, it is likely that Rockport received preferred stock in exchange for its initial $4 million investment and therefore controls at least 13.75% of Aspen Aerogels and possibly more, assuming that There are no additional venture capitalists. If Rockport's shareholder rights agreement contained an anti-dilution provision, it would be able to maintain its ownership percentage without investing additional capital and therefore would not necessarily be......in the middle of the paper market.. ....this, the real estate market, fire protection, technical insulation, etc., which makes a large number of potential buyers wait for the products. As long as Aspen can establish a clear marketing and sales strategy and build good business alliances with large organizations in their potential markets, sales growth will definitely increase. Additionally, the barrier to enter the aerogel field is high. Aspen has already filed for patent protection for its production process and is continuing R&D activities to reduce manufacturing costs. The filed patent will guarantee Aspen a temporary advantage in this area. The management team's strong experience helps reduce the risk associated with Aspen's aerogels, as Lee, Aspen's CTO, is one of very few executives with expertise in this area and is devoting effort to aerogel research for a long time..